[ad_1]

Shares of Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) traded down 3.5% during trading on Wednesday . The stock traded as low as $1.43 and last traded at $1.38. 45,513 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 444,843 shares. The stock had previously closed at $1.43.

Separately, Zacks Investment Research lowered Corindus Vascular Robotics from a “buy” rating to a “hold” rating in a report on Tuesday, November 13th.

Several hedge funds have recently added to or reduced their stakes in the company. Jane Street Group LLC bought a new position in Corindus Vascular Robotics during the fourth quarter valued at $36,000. HRT Financial LLC bought a new position in Corindus Vascular Robotics during the fourth quarter valued at $44,000. Millennium Management LLC grew its holdings in Corindus Vascular Robotics by 1.0% during the fourth quarter. Millennium Management LLC now owns 7,088,692 shares of the medical equipment provider’s stock valued at $5,955,000 after purchasing an additional 68,250 shares during the period. Virtu Financial LLC bought a new position in Corindus Vascular Robotics during the fourth quarter valued at $64,000. Finally, Citadel Advisors LLC boosted its holdings in shares of Corindus Vascular Robotics by 205.4% in the third quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock worth $164,000 after acquiring an additional 77,829 shares during the period.

COPYRIGHT VIOLATION WARNING: “Corindus Vascular Robotics (CVRS) Stock Price Down 3.5%” was first reported by Fairfield Current and is the sole property of of Fairfield Current. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright legislation. The legal version of this piece can be accessed at https://www.fairfieldcurrent.com/news/2019/03/08/corindus-vascular-robotics-cvrs-stock-price-down-3-5.html.

About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.

Further Reading: Swap

Receive News & Ratings for Corindus Vascular Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Corindus Vascular Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

Source link